Charles A. McWherter
2016
In 2016, Charles A. McWherter earned a total compensation of $587K as Senior Vice President and Chief Scientific Officer at Cymabay Therapeutics, a 48% decrease compared to previous year.
Compensation breakdown
| Bonus | $136,125 |
|---|---|
| Option Awards | $67,474 |
| Salary | $360,356 |
| Other | $23,070 |
| Total | $587,025 |
McWherter received $360.4K in salary, accounting for 61% of the total pay in 2016.
McWherter also received $136.1K in bonus, $67.5K in option awards and $23.1K in other compensation.
Rankings
In 2016, Charles A. McWherter's compensation ranked 10,615th out of 14,075 executives tracked by ExecPay. In other words, McWherter earned more than 24.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,615 out of 14,075 | 25th |
Division Manufacturing | 4,117 out of 5,489 | 25th |
Major group Chemicals And Allied Products | 1,457 out of 1,895 | 23rd |
Industry group Drugs | 1,171 out of 1,538 | 24th |
Industry Pharmaceutical Preparations | 915 out of 1,176 | 22nd |
Source: SEC filing on April 19, 2017.
McWherter's colleagues
We found two more compensation records of executives who worked with Charles A. McWherter at Cymabay Therapeutics in 2016.
News
Cymabay Therapeutics CEO Sujal Shah's 2022 pay rises 16% to $2.6M
April 19, 2023
Cymabay Therapeutics CEO Sujal Shah's 2021 pay slips 16% to $2.2M
April 26, 2022
Cymabay Therapeutics CEO Sujal Shah's 2019 pay jumps 32% to $2.6M
May 15, 2020
Cymabay Therapeutics General Counsel Paul Quinlan receives $3M in 2018
April 26, 2019